Skip to main content
Premium Trial:

Request an Annual Quote

New Products: OGT's CytoSure Molecular Arrays, Golden Helix's SNP & Variation Suite 8

Premium

Oxford Gene Technology has expanded its menu of CytoSure Molecular Arrays for the investigation of DNA copy number variants underlying genetic disorders.

OGT and collaborators at Emory Genetics Laboratory designed the comparative genomic hybridization arrays, which target genes associated with 22 different diseases and disorders. A full list of the chips is available on the Oxford, UK-based firm's website.

Representatives from OGT and EGL will be discussing the arrays during the American College of Medical Genetics and Genomics' annual meeting, which will be held later this month in Nashville, Tenn.

BioArray News in November interviewed Madhuri Hegde, executive director of EGL, about her work with OGT.


Golden Helix this week introduced the eighth version of its SNP & Variation Suite software, a collection of analytic tools for managing, analyzing, and visualizing multifaceted genomic and phenotypic data intended for users undertaking next-generation sequencing studies, genome-wide association studies, and copy number analysis.

According to the Bozeman, Mont.-based bioinformatics company, SVS8 offers new analysis capabilities including Haplotype Trend Regression, Fst by Marker, and DNA-Seq additions. It also offers new visualization tools, annotation track and data handling improvements, and workflow streamlining.

BioArray News recently discussed SVS8 with Bryce Christensen, director of services at Golden Helix.

The Scan

University of Michigan President Fired

Mark Schlissel, the president of the University of Michigan, has been fired after an investigation into allegations he had an affair with a subordinate, the Washington Post reports.

Recommendation to Drop Charges

The Wall Street Journal says federal prosecutors recommended charges against MIT's Gang Chen, who was caught up by the China Initiative, be dropped.

Mix 'Em Together

The Guardian reports Moderna is planning to have a combination SARS-CoV-2, influenza, and RSV vaccine by the 2023 flu season.

PNAS Papers on Earth BioGenome Project, SETX Knockouts, Pig Model of Cystic Fibrosis

In PNAS this week: Earth BioGenome Project reports progress, analysis of cells missing the progressive neurodegenerative disease-linked SETX gene, and more.